The NHSA is delighted to announce the 15 shortlisted companies that are moving to stage 2 of our International Health Tech R&D Pilot Programme.

The successful companies are (in alphabetical order):

• Cognishine Therapy and Education
• Cordio Medical
• Donisi health
• GistMD
• Ikko Health
• ImPlio
• Kemtai
• Nanovation
• Neurotrigger
• Pathkeeper
• Pulsenmore
• QLOG Technologies
• Sherman Diagnostics
• Visionsense
• Votis

The shortlisted companies will now work with NHSA members to develop their project plans to bring world leading R&D to the UK.  They will receive support from the NHSA, the UK Israel Tech Hub and HealthIL to develop their ideas and deliver maximum impact for their business and UK patients.

The International Health Tech R&D pilot programme is led by the NHSA in the UK and the Israeli Innovation Authority in Israel to identify unmet clinical needs in the UK and identify potential solutions. We connect cutting edge health technologies to UK research and innovation expertise to stimulate transnational partnerships, accelerate the availability of medical innovations to the public, introduce Israeli healthcare technology to global markets, and advance the development of discoveries for the benefit of patients all over the world.